101 related articles for article (PubMed ID: 10455430)
1. Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking.
Hildinger M; Schilz A; Eckert HG; Bohn W; Fehse B; Zander A; Ostertag W; Baum C
Gene Ther; 1999 Jul; 6(7):1222-30. PubMed ID: 10455430
[TBL] [Abstract][Full Text] [Related]
2. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
3. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.
Suzuki M; Sugimoto Y; Tsukahara S; Okochi E; Gottesman MM; Tsuruo T
Clin Cancer Res; 1997 Jun; 3(6):947-54. PubMed ID: 9815770
[TBL] [Abstract][Full Text] [Related]
4. A comparative evaluation of gene transfer into blood cells using the same retroviral backbone for independent expression of the EGFP and deltaLNGFR marker genes.
Giaretta I; Madeo D; Bonaguro R; Cappellari A; Rodeghiero F; Giorgio P
Haematologica; 2000 Jul; 85(7):680-9. PubMed ID: 10897118
[TBL] [Abstract][Full Text] [Related]
5. Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells.
Knipper R; Kuehlcke K; Schiedlmeier B; Hildinger M; Lindemann C; Schilz AJ; Fauser AA; Fruehauf S; Zeller WJ; Ostertag W; Eckert HG; Baum C
Gene Ther; 2001 Feb; 8(3):239-46. PubMed ID: 11313796
[TBL] [Abstract][Full Text] [Related]
6. A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance.
Wang J; Chen Z; Xia X; Lu D; Xue J; Ruan C
Chin Med J (Engl); 2001 Jan; 114(1):25-9. PubMed ID: 11779430
[TBL] [Abstract][Full Text] [Related]
7. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
Guo C; Jin X
Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
[TBL] [Abstract][Full Text] [Related]
8. [Efficient expression of multidrug resistance gene mdr1 in retroviral vector under control of an internal ribosome entry site].
Fu J; Chen Z; Wang W
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):619-22. PubMed ID: 11263327
[TBL] [Abstract][Full Text] [Related]
9. Genetic modification of hematopoietic progenitor cells for combined resistance to 4-hydroperoxycyclophosphamide, vincristine, and daunorubicin.
Wang JS; Fang Q; Sun DJ; Chen J; Zhou XL; Lin GW; Lu HZ; Fei J
Acta Pharmacol Sin; 2001 Oct; 22(10):949-55. PubMed ID: 11749781
[TBL] [Abstract][Full Text] [Related]
10. Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors.
Hildinger M; Fehse B; Hegewisch-Becker S; John J; Rafferty JR; Ostertag W; Baum C
Hum Gene Ther; 1998 Jan; 9(1):33-42. PubMed ID: 9458240
[TBL] [Abstract][Full Text] [Related]
11. Retroviral transfer of the multidrug resistance-1 gene into lineage-committed and primitive hemopoietic cells.
Fruehauf S; Boesen JJ; Breems DA; Höft R; Hundsdörfer P; Zeller WJ; Löwenberg B; Ploemacher RE; Haas R; Valerio D
Stem Cells; 1995 Dec; 13 Suppl 3():93-9. PubMed ID: 8747995
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of bicistronic retroviral vectors encoding the multidrug transporter and beta-galactosidase or green fluorescent protein.
Aran JM; Gottesman MM; Pastan I
Cancer Gene Ther; 1998; 5(4):195-206. PubMed ID: 9694071
[TBL] [Abstract][Full Text] [Related]
13. Genetic marking with the DeltaLNGFR-gene for tracing goat cells in bone tissue engineering.
Kruyt MC; Stijns MM; Fedorovich NE; De Bruijn JD; Van Blitterswijk CA; Verbout AJ; Rozemuller H; Hagenbeek A; Dhert WJ; Martens AC
J Orthop Res; 2004 Jul; 22(4):697-702. PubMed ID: 15183423
[TBL] [Abstract][Full Text] [Related]
14. FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells.
Hildinger M; Eckert HG; Schilz AJ; John J; Ostertag W; Baum C
Gene Ther; 1998 Nov; 5(11):1575-9. PubMed ID: 9930313
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
[TBL] [Abstract][Full Text] [Related]
16. Frape-1 and Frape-3: two different recombinant retroviruses encoding the same human marker gene.
Ng YY; Veenhuizen P; Lokhorst H; Staal FJ
Cancer Gene Ther; 2000 Apr; 7(4):624-8. PubMed ID: 10811481
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an MDR1 retroviral bicistronic vector for correction of X-linked severe combined immunodeficiency.
Kleiman SE; Pastan I; Puck JM; Gottesman MM
Gene Ther; 1998 May; 5(5):671-6. PubMed ID: 9797872
[TBL] [Abstract][Full Text] [Related]
18. Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I.
Pan D; Aronovich E; McIvor RS; Whitley CB
Gene Ther; 2000 Nov; 7(21):1875-83. PubMed ID: 11110421
[TBL] [Abstract][Full Text] [Related]
19. Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivo.
Buss EC; Laufs S; Naundorf S; Kuehlcke K; Nagy KZ; Zeller WJ; Fruehauf S
Cytotherapy; 2006; 8(6):562-9. PubMed ID: 17148033
[TBL] [Abstract][Full Text] [Related]
20. Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo.
Guo CB; Li YC; Jin XQ
Cancer Chemother Pharmacol; 2006 Jul; 58(1):40-9. PubMed ID: 16284790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
